Clinical Trial Update: Severe Erythema Multiforme - CORTICO [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for CORTICO targeting severe erythema multiforme; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythema Multiforme

Drugs mentioned

• CORTICO

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Erythema Multiforme | Phase 3 | Status: NOT_YET_RECRUITING